Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker-Reference-Cited by-同舟云学术

Bridging Sunitinib Exposure to Time‐to‐Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker

Author:

Ait‐Oudhia S¹,Mager DE²,Pokuri V³,Tomaszewski G³,Groman A³,Zagst P³,Fetterly G⁴,Iyer R³

Affiliation:

1. Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of PharmacyUniversity of FloridaOrlando Florida USA

2. Department of Pharmaceutical SciencesUniversity at Buffalo, State University of New YorkBuffalo New York USA

3. Department of Medical OncologyRoswell Park Cancer InstituteBuffalo New York USA

4. Clinical Pharmacology and Regulatory AffairsBuffalo New York USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

Reference50 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献